Loss of HES1 Expression Indicates Worse Prognosis in Lymph Node Negative Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Li, Yuan [1 ]
Cai, Zhenjian [2 ]
Awadallah, Amad [3 ]
Zhou, Lan [4 ]
Xin, Wei [5 ]
机构：
[1] Peking Union Med Coll Hosp, Redondo Beach, CA USA
[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[3] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Cleveland Med Ctr, Solon, OH USA
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1694
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Loss of HES1 Expression Indicates Worse Prognosis in Lymph Node Negative Pancreatic Ductal Adenocarcinoma
    Li, Yuan
    Cai, Zhenjian
    Awadallah, Amad
    Zhou, Lan
    Xin, Wei
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [2] Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma
    Ahadi, Mahsa
    Andrici, Juliana
    Sioson, Loretta
    Sheen, Amy
    Clarkson, Adele
    Gill, Anthony J.
    [J]. HUMAN PATHOLOGY, 2016, 57 : 91 - 97
  • [3] Loss of Phosphomannose Isomerase Expression Associated with Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Alipour, Zahra
    Agostini-Vulaj, Diana
    Findeis-Hosey, Jennifer
    Drage, Michael
    Liu, Lei
    Zhou, Zhongren
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1631 - 1631
  • [4] Loss of Phosphomannose Isomerase Expression Associated with Worse Prognosis in Pancreatic Ductal Adenocarcinoma
    Alipour, Zahra
    Agostini-Vulaj, Diana
    Findeis-Hosey, Jennifer
    Drage, Michael
    Liu, Lei
    Zhou, Zhongren
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1631 - 1631
  • [5] Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma
    Li, Yu-Feng
    Xiang, Yu-Cheng
    Zhang, Qiu-Qiang
    Wang, Wei-Lin
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (04) : 644 - +
  • [6] High Coagulation Activity Indicates Worse Outcome in Pancreatic Ductal Adenocarcinoma
    Mattila, N.
    Lassila, R.
    Haglund, C.
    Seppanen, H.
    [J]. PANCREAS, 2019, 48 (10) : 1488 - 1489
  • [7] Weak HIF-1 alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
    Leppanen, Joni
    Helminen, Olli
    Huhta, Heikki
    Kauppilau, Joonas H.
    Isohookana, Joel
    Haapasaari, Kirsi-Maria
    Parkkila, Seppo
    Saarniol, Juha
    Lehenkari, Petri P.
    Karttunen, Tuomo J.
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2018, 16
  • [8] Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
    Joni Leppänen
    Olli Helminen
    Heikki Huhta
    Joonas H. Kauppila
    Joel Isohookana
    Kirsi-Maria Haapasaari
    Seppo Parkkila
    Juha Saarnio
    Petri P. Lehenkari
    Tuomo J. Karttunen
    [J]. World Journal of Surgical Oncology, 16
  • [9] Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model
    Hidalgo-Sastre, Ana
    Brodylo, Roxanne L.
    Lubeseder-Martellato, Clara
    Sipos, Bence
    Steiger, Katja
    Lee, Marcel
    von Figura, Guido
    Gruenwald, Barbara
    Zhong, Suyang
    Trajkovic-Arsic, Mania
    Neff, Florian
    Schmid, Roland M.
    Siveke, Jens T.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (11): : 2934 - 2944
  • [10] Loss of Hes1 Is a Common Finding in Human Pancreatic Ductal Carcinoma and Is Associated with Loss of SMAD4
    Cui, Min
    Cai, Zhenjian
    Awadallah, Amad
    Xin, Wei
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 443A - 443A
12345